loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Tafenoquine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Tafenoquine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,132Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    60 Degrees Pharma Closes $4M Private Placement At-Market Under Nasdaq
    60 Degrees Pharma Closes $4M Private Placement At-Market Under Nasdaq

    06 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942158/0/en/60-Degrees-Pharmaceuticals-Inc-Announces-Closing-of-4-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    06 Sep 2024
    Share Share
    60 Degrees Pharmaceuticals Announces $4M Private Placement
    60 Degrees Pharmaceuticals Announces $4M Private Placement

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940442/0/en/60-Degrees-Pharmaceuticals-Inc-Announces-4-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
    60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

    14 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/14/2930260/0/en/60-Degrees-Pharmaceuticals-Announces-Second-Quarter-2024-Results.html

    GLOBENEWSWIRE
    14 Aug 2024
    Share Share
    60 Degrees Pharma Supports UK's SJ733 Study With ARAKODA NDA Access
    60 Degrees Pharma Supports UK's SJ733 Study With ARAKODA NDA Access

    12 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/12/2928485/0/en/60-Degrees-Pharma-Provides-University-of-Kentucky-with-Right-of-Reference-to-ARAKODA-NDA-in-Support-of-SJ733-Phase-IIb-Study.html

    GLOBENEWSWIRE
    12 Aug 2024
    Share Share
    60 Degrees Pharma Signs Agreements For Tafenoquine Babesiosis Trial Sites
    60 Degrees Pharma Signs Agreements For Tafenoquine Babesiosis Trial Sites

    19 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/19/2915856/0/en/60-Degrees-Pharmaceuticals-Signs-Clinical-Trial-Agreements-With-All-Planned-Trial-Sites-for-Tafenoquine-Babesiosis-Study.html

    GLOBENEWSWIRE
    19 Jul 2024
    Share Share
    60 Degrees Pharma Gets IRB Approval For Tafenoquine In Babesiosis
    60 Degrees Pharma Gets IRB Approval For Tafenoquine In Babesiosis

    09 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/07/09/2910173/0/en/60-Degrees-Pharma-Announces-IRB-Approval-of-Clinical-Study-of-Tafenoquine-for-Treatment-of-Babesiosis-in-Immunocompromised-Patients-with-Persistent-Babesia-microti-Despite-Prior-Tr.html

    GLOBENEWSWIRE
    09 Jul 2024
    Share Share